Relationship between calcium supplements and cardiovascular disease
Phase 4
Completed
- Conditions
- Endothelial functionArterial stiffnessCardiovascular - Coronary heart disease
- Registration Number
- ACTRN12612000232831
- Lead Sponsor
- Dr Morton Burt
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Age > 50 years
Exclusion Criteria
Taking calcium or vitamin D (>300 IU/day) in the last 3 months
Taking proton pump inhibitors in last 3 months
Taking calcium channel blockers in the last 3 months
Primary hyperparathyroidism
Diabetes mellitus
Atrial fibrillation
Raynaud’s phenomenon
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Endothelial function assessed by ENDO-PAT 2000[Before and 3 hours after taking calcium supplement]
- Secondary Outcome Measures
Name Time Method Arterial stiffness assessed by pulse wave analysis[Before and 3 hours after taking calcium supplement]